Recombinant Human Adenovirus 5 Injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant Human Adenovirus 5 Injection, covering 2024-06-12 to 2024-06-12. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of AK104 Combined With Chemotherapy and Recombinant Human Adenovirus 5 Injection in Cervical Cancer [Phase 2]